Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:ARTV 17 October 2025 - 16 December 2025

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics (ARTV) Stock: Today’s News (Dec. 16, 2025), Why Shares Spiked, Analyst Forecasts, and What Investors Are Watching Next

Artiva Biotherapeutics shares surged to around $6.30 on December 16 after trading between $4.08 and $7.25 in a session with volume near 48 million shares. CEO Fred Aslan disclosed selling 3,187 shares at $6.00 each on December 15 under a pre-arranged plan, according to an SEC Form 4. The company’s market cap stands near $155 million.
16 December 2025
Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics shares surged nearly 100% in after-hours trading Oct. 16 after the FDA granted Fast Track status to its AlloNK cell therapy for refractory rheumatoid arthritis. The stock jumped from a $2.77 close to as high as $6.33. Over 20 patients have received AlloNK in trials, with key safety and mechanistic data expected by mid-November. Artiva plans to begin a pivotal Phase 3 trial in 2026, pending results.
17 October 2025
·

Stock Market Today

  • Quarter 4 Review: Applied Materials vs Semiconductor Manufacturing Sector Performance
    March 20, 2026, 8:54 PM EDT. Q4 earnings for semiconductor manufacturing stocks reveal strong sector momentum, led by Applied Materials and peers. Applied Materials (NASDAQ:AMAT) posted $7.01 billion in revenue, down 2.1% year-on-year but beating analyst expectations by 1.8%, with upbeat guidance fueled by AI industry investments. The stock surged 9.3% post-results, now trading at $358.81. Teradyne (NASDAQ:TER) topped the group with 43.9% revenue growth to $1.08 billion, surpassing forecasts by 11%, its stock climbing 21.9% since reporting. The overall group of 14 semiconductor manufacturing stocks beat revenue estimates by 3%, with shares rising an average 3.6%. Market watchers highlight ongoing demand from AI, 5G, and smart vehicle sectors driving equipment needs amid chip fabrication complexity.
Go toTop